Endogenous Bioelectric Current
Biological patterns of life are the “visible expression of an underlying bioelectrical pattern” Sinnott, 1960. Electrical currents, carried by mobile charged ions, within cellular environment
April 23, 2023
We are developing E-Plasters® to help “re-boot” the body’s natural bioelectric current to promote tissue healing/regeneration.
Our E-Plaster® digital platform with IoT connects patients and providers to improve productivity and quality of life.
Our proprietary catalogue of materials, BiomimInks™ enables us to offer bespoke solutions to repair/ rejuvenate a range of tissue types, as well as enable leading life-sciences research to explore cell/tissue behaviour in 3D biomimetic environment.
A person has a better chance of living five years with breast, prostate or colon cancer than a diabetic with a foot ulcer.
Guest et al; Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018; doi: 10.1136/bmjopen-2020-045253
NuTissu’s unique portfolio of photopolymers, BiomimInks® and biomaterials-based technology present a range of properties to completely and rapidly heal wounds, that include antimicrobial defence, skin epithelialisation, and crucially, enable the delivery of electrical-stimulation therapy with digital-health technologies through everyday consumer electronics.
Externally applied electric currents in wounded/damaged tissue can mimic the endogenous currents which facilitate wound healing. Our product, E-Plaster® with bioelectric stimulation aims to mimic this natural current of injury.
We are leveraging on IoT and digital health technologies to enable the solutions to be patient centric with the E-Plaster® App as well as enable our biomaterials to mimic optimal physiological functions with 3D printing.
Founder of NuTissu with 10+ years of experience following her doctorate in Tissue Engineering and Regenerative Medicine, has been executing projects in surgical MedTech and related. She brings a unique approach to solving wounds combining biomaterials, bioelectricity and digital health technology.
Stephen Carter is Founder of The Intellectual Property Works, an intellectual property consultancy. He is a UK and European Patent Attorney with over 25 years’ experience and is recognised by IAM300 as a leading IP strategist. Having spent many years as a partner in two London-based law firms, Stephen now acts as an advisor to innovative start-ups and SMEs.
Steven Jeffery is a Consultant Burns and Plastic Surgeon and is Professor of Wound Study and Birmingham City University. He has extensive experience of complex wound management and is also an Internal Clinician for BSI.
Karen is a solicitor, founder and managing director of a City Law Firm and brings a wealth of experience to secure legal and business terms to maximise the commercial value of NuTissu.
Antonio is a versatile, and highly experienced Full-Stack developer with over 20 years of experience in Software Development and passion for software architectures.
Avira is a graduate in Computer Science and Engineering (BTech) and has 8+ years experience as a Software Engineer/Full-Stack Developer in a range of domains including projects supporting workflows & automating patient engagement, and has contributed to the development of cutting-edge applications across the globe.
Dipak has a Master’s degree in Electrical and Electronic Engineering from University of Greenwich (MSc, First Class Honours ) with extensive experience in electronics systems.
Keiran is a graduate in Forensic Science, BSc (Hons) and an Industrial Research Chemist with extensive yrs of experience in multiple project developments in bio based, medical, cosmetic, and dental polymers for healthcare/ consumer markets.
Biological patterns of life are the “visible expression of an underlying bioelectrical pattern” Sinnott, 1960. Electrical currents, carried by mobile charged ions, within cellular environment
Minister for Veterans’ Affairs Johnny Mercer joined with Nutissu staff to announce Veterans Health Innovation Fund awards aiming to improve the UK’s capability to save
Abstract: Hollow, tubular organs including oesophagus, trachea, stomach, intestine, bladder and urethra may require repair or replacement due to disease. Current treatment is considered an
There is an unmet need for artificial tissue to address current limitations with donor organs and problems with donor site morbidity. Despite the success with
A Senior Electronics Engineer (with Medical Device/IoT go-to market experience).
![lab[98]](https://nutissu.com/wp-content/uploads/2023/05/lab98.jpg)
Westbourne Studios, 242, Acklam Road, London, W10 5JJ
© NuTissu Limited. All rights reserved.
Created by Dentons Digital